Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSANTOS, Carina C.
dc.contributor.authorLIMA, Fernanda W. de M.
dc.contributor.authorMAGNO, Laio
dc.contributor.authorSOARES, Fabiane
dc.contributor.authorFERRAZ, Dulce
dc.contributor.authorGRANGEIRO, Alexandre
dc.contributor.authorZUCCHI, Eliana Miura
dc.contributor.authorPREAU, Marie
dc.contributor.authorMABIRE, Xavier
dc.contributor.authorMATOS, Helen R. S. S.
dc.contributor.authorDOURADO, Ines
dc.contributor.authorCOBra Study Grp
dc.date.accessioned2023-04-14T18:06:34Z
dc.date.available2023-04-14T18:06:34Z
dc.date.issued2023
dc.description.abstractBackground Brazil was strongly affected by the COVID-19 pandemic and the impact of the pandemic on sexual and gender minorities' youth remains unknown. This study aimed to estimate the seroprevalence of SARS-CoV-2 antibodies and associated factors among adolescent men who have sex with men (AMSM) and transgender women (ATGW) participants of a human immunodeficiency virus (HIV) pre-exposure prophylaxis cohort study (PrEP1519).Methods This is a cross-sectional design conducted between June and October 2020 in Salvador, Brazil. Serum samples were collected from AMSM and ATGW aged 16-21 years between June-October 2020. IgG and IgM anti-SARS-CoV-2 were detected by chemiluminescence immunoassay, and data were collected through a socio-behavioral questionnaire.Results Among the 137 participants, the seroprevalence of anti-SARS-CoV-2 IgG and IgM was 20.4%; 16.8% of the participants were positive for IgG, and 11.7% for IgM. In the multivariable analysis, the seroprevalence was two times higher among those who never wore masks (OR= 2.22; 95% CI: 1.08-4.57) and among those who believed that they could be easily cured of the disease (OR= 2.05; 95% CI: 1.05-4.01).Conclusions The high seroprevalence of SARS-CoV-2 antibodies among gender and sexual minority youth seems to be informed by behaviors and attitudes that contrast with public health measures and the potential severity of the disease when vaccination was still not available.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus
dc.description.sponsorshipTGW
dc.description.sponsorshipSalvador City Health Departments
dc.description.sponsorshipDiversity Center of the Bahia State Justice and Human Rights Department
dc.description.sponsorshipDepartment of Chronic Diseases and Sexually Transmitted Infections of the Brazilian Ministry of Health
dc.description.sponsorshipUNITAID [2017-15-FIOTECPrEP]
dc.description.sponsorshipAgence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS)
dc.identifier.citationBMC PUBLIC HEALTH, v.23, n.1, article ID 61, 8p, 2023
dc.identifier.doi10.1186/s12889-022-14969-x
dc.identifier.eissn1471-2458
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/53130
dc.language.isoeng
dc.publisherBMCeng
dc.relation.ispartofBMC Public Health
dc.rightsopenAccesseng
dc.rights.holderCopyright BMCeng
dc.subjectCOVID-19eng
dc.subjectAntibodieseng
dc.subjectPrevalenceeng
dc.subjectMen who have sex with meneng
dc.subjectTransgender womeneng
dc.subjectAdolescenteng
dc.subjectBrazileng
dc.subject.othermodelseng
dc.subject.otherriskeng
dc.subject.wosPublic, Environmental & Occupational Healtheng
dc.titleSeroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazileng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countrySuíça
hcfmusp.affiliation.countryisoch
hcfmusp.author.externalSANTOS, Carina C.:Univ Fed Bahia, Fac Farm, Dept Anal Clin & Toxicol, Salvador, Brazil
hcfmusp.author.externalLIMA, Fernanda W. de M.:Univ Fed Bahia, Fac Farm, Dept Anal Clin & Toxicol, Salvador, Brazil
hcfmusp.author.externalMAGNO, Laio:Univ Estado Bahia, Dept Ciencias Vida, Salvador, Brazil; Univ Fed Bahia, Inst Saude Colet, Salvador, Brazil
hcfmusp.author.externalSOARES, Fabiane:Univ Fed Bahia, Inst Saude Colet, Salvador, Brazil
hcfmusp.author.externalFERRAZ, Dulce:Fundacao Oswaldo Cruz, Escola FIOCRUZ Governo, Brasilia, Brazil; Univ Lyon 2, Pole Social Psychol, UMR Radiat Def Sante Environm 1296, Lyon, France; Univ Lausanne, Fac Social & Polit Sci, PHASE Psychol Hlth Aging & Sport Examinat, Lausanne, Switzerland
hcfmusp.author.externalZUCCHI, Eliana Miura:Univ Catolica Santos, Programa Pos Grad Saude Colet, Santos, Brazil
hcfmusp.author.externalPREAU, Marie:Univ Lyon 2, Pole Social Psychol, UMR Radiat Def Sante Environm 1296, Lyon, France; Univ Lausanne, Inst Psychol, Lausanne, Switzerland
hcfmusp.author.externalMABIRE, Xavier:Univ Lyon 2, Pole Social Psychol, UMR Radiat Def Sante Environm 1296, Lyon, France; Univ Lausanne, Fac Social & Polit Sci, PHASE Psychol Hlth Aging & Sport Examinat, Lausanne, Switzerland
hcfmusp.author.externalMATOS, Helen R. S. S.:Univ Fed Bahia, Fac Farm, Dept Anal Clin & Toxicol, Salvador, Brazil
hcfmusp.author.externalDOURADO, Ines:Univ Fed Bahia, Inst Saude Colet, Salvador, Brazil
hcfmusp.citation.scopus2
hcfmusp.contributor.author-fmusphcALEXANDRE DOMINGUES GRANGEIRO
hcfmusp.description.articlenumber61
hcfmusp.description.issue1
hcfmusp.description.volume23
hcfmusp.origemWOS
hcfmusp.origem.pubmed36624484
hcfmusp.origem.scopus2-s2.0-85145955885
hcfmusp.origem.wosWOS:000913897300006
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceAlmeida N, 2004, SOC SCI MED, V59, P1339, DOI 10.1016/j.socscimed.2003.11.037eng
hcfmusp.relation.referenceArcher KJ, 2007, COMPUT STAT DATA AN, V51, P4450, DOI 10.1016/j.csda.2006.07.006eng
hcfmusp.relation.referenceBAHIA. Secretaria da Saude do Estado da Bahia (Sesab), 2020, BAHIA ESTA 5 LUGAR Neng
hcfmusp.relation.referenceBerenguer J, 2021, CLIN MICROBIOL INFEC, V27, P1678, DOI 10.1016/j.cmi.2021.06.023eng
hcfmusp.relation.referenceBo YC, 2021, INT J INFECT DIS, V102, P247, DOI 10.1016/j.ijid.2020.10.066eng
hcfmusp.relation.referenceBRASIL, 2022, PAINEL CASOS DOENCAeng
hcfmusp.relation.referenceCarvalho Herica Emilia Félix de, 2020, Rev. Bras. Enferm., V73, pe20200913, DOI 10.1590/0034-7167-2020-0913eng
hcfmusp.relation.referenceDing YN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237626eng
hcfmusp.relation.referenceDourado I, 2020, AIDS BEHAV, V24, P1994, DOI 10.1007/s10461-020-02927-weng
hcfmusp.relation.referenceFerraz D, 2023, ARCH SEX BEHAV, V52, P689, DOI 10.1007/s10508-022-02364-xeng
hcfmusp.relation.referenceFerraz D, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045258eng
hcfmusp.relation.referenceHallal PC, 2020, LANCET GLOB HEALTH, V8, pE1390, DOI 10.1016/S2214-109X(20)30387-9eng
hcfmusp.relation.referenceJassanoff S, 2021, COMP COVID RESPONSEeng
hcfmusp.relation.referenceKleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.xeng
hcfmusp.relation.referencede Sousa AFL, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18063266eng
hcfmusp.relation.referencede Sousa AFL, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00202420, 10.1590/0102-311x00202420]eng
hcfmusp.relation.referenceMagno L, 2022, ARCH SEX BEHAV, P1eng
hcfmusp.relation.referenceNorton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304eng
hcfmusp.relation.referencePandya A, 2022, J HUM RIGHTS SOC WOR, V7, P148, DOI 10.1007/s41134-021-00184-yeng
hcfmusp.relation.referencePinto VC, 2021, INT J INFECT DIS, V108, P20, DOI 10.1016/j.ijid.2021.04.086eng
hcfmusp.relation.referencePoteat TC, 2020, JAIDS-J ACQ IMM DEF, V85, pE67, DOI 10.1097/QAI.0000000000002490eng
hcfmusp.relation.referenceRatcliffe H, 2022, ARCH DIS CHILD, DOI 10.1136/archdischild-2022-324375eng
hcfmusp.relation.referenceRella SA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95025-3eng
hcfmusp.relation.referenceSalyer SJ, 2021, LANCET, V397, P1265, DOI 10.1016/S0140-6736(21)00632-2eng
hcfmusp.relation.referenceSanchez TH, 2020, AIDS BEHAV, V24, P2024, DOI 10.1007/s10461-020-02894-2eng
hcfmusp.relation.referenceSantos GM, 2021, AIDS BEHAV, V25, P311, DOI 10.1007/s10461-020-02969-0eng
hcfmusp.relation.referenceUN Country Team in Djibouti, 2020, REP DJIB COVID 19 SIeng
hcfmusp.relation.referenceWang ZC, 2020, NAT MED, V26, P458, DOI 10.1038/s41591-020-0823-6eng
hcfmusp.relation.referenceWorldometer, 2022, COVID 19 COR PANDeng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication3d094e2e-f610-41a2-978a-db373a333186
relation.isAuthorOfPublication.latestForDiscovery3d094e2e-f610-41a2-978a-db373a333186
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_SANTOS_Seroprevalence_of_antiSARSCoV2_antibodies_and_factors_associated_with_.PDF
Tamanho:
877.63 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/Outros
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - LIM/39
Artigos e Materiais de Revistas Científicas - ODS/03